Concepedia

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner, Frank O. Nestlé, Alexander Enk, E.-B. Bröcker, Stephan Grabbe, Werner Rittgen, Lutz Edler, Antje Sucker,

Annals of Oncology · 2006 · 466 citations · 21 references

DOIFull text

Open access

Concepts

References

21

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Cancer immunotherapy: moving beyond current vaccines

Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo · Nature Medicine · 2004 · 3K citations · Full text

, , +9

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

, , +7

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald et al. · Journal of Clinical Oncology · 2001 · 2.4K citations

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al. · Nature Medicine · 1998 · 1.8K citations

, , +10